Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates
- Thursday, May 11, 2023, 7:01
- Finance
- Add a comment
AUSTIN, Texas, May 11, 2023 /PRNewswire/ — Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse (the “Company” or “Anebulo”), today announced…
About the Author
adminasapcorp has written 41611 stories on this site.